Skip to main content
. 2017 Sep 7;12(9):e0184354. doi: 10.1371/journal.pone.0184354

Table 3. Comparison of pulmonary vein and non-pulmonary vein mediated AF.

Non-PV mediated AF
(N = 33)		 PV-mediated AF
(N = 91)		 P-value
Age at First Ablation (years) 64 (60,71) 60 (52,67) 0.01*
Male gender (%) 21 (64%) 69 (76%) 0.19
Race

  • White

  • Black

  • Other

 -
32 (97%)
1 (3%)
0 (0%)		 -
89 (98%)
2 (2%)
0 (0%)		 0.79
Ethnicity

  • Non-Hispanic

  • Hispanic

 -
33 (100%)
0 (0%)		 -
90 (99%)
1 (1%)		 0.43
Height (cm) 178 (170,185) 179 (170,185) 0.73
Body Mass Index (kg/m2) 31 (26,34) 29 (26,33) 0.72
Non-Paroxysmal AF 27 (82%) 32 (35%) <0.001*
Lone AF 4 (12%) 16 (18%) 0.45
Time Since AF Diagnosis (years) 4.8 (1.0,8.0) 3.4 (1.3,6.2) 0.64
Hypertension 27 (82%) 60 (66%) 0.08
Diabetes 10 (30%) 14 (15%) 0.07
Congestive Heart Failure 4 (12%) 4 (4%) 0.14
Coronary Artery Disease 10 (30%) 32 (35%) 0.61
Left Atrial Size (cm) 4.2 (3.6,4.8) 4.0 (3.3,4.4) 0.04*
Left Ventricular Ejection Fraction (%) 55 (54,55) 55 (55,55) 0.21
Pulmonary Vein Anatomy

  • 4 separate PVs

  • Common Left PV

  • Common Right PV

  • Common Left and Right PV

 -
29 (91%)
3 (9%)
0 (0%)
0 (0%)		 -
84 (92%)
4 (4%)
1 (1%)
0 (0%)		 0.66
Accessory Pulmonary Vein (yes/no) 5 (15%) 15 (17%) 0.86
Common Pulmonary Vein (yes/no) 3 (9%) 5 (6%) 0.45
Antiarrhythmic Drug Use Prior to Ablation

  • None

  • Class I

  • Class III

  • Amiodarone

 -
5 (15%)
7 (21%)
12 (36%)
9 (27%)		 -
10 (11%)
31 (35%)
33 (37%)
15 (17%)		 0.38
Pulmonary Vein Isolation Technique

  • Radiofrequency

  • Cyroballoon

 -
29 (88%)
4 (12%)		 -
82 (90%)
9 (10%)		 0.72

* p = < .05